Trials Annotator

Trial NCT04558892

View at ClinicalTrials.gov

Org. Study IDs: 5/8952 (443)

Last trial update was posted on 2023-01-30

MeSH Interventions

Enoxaparin

MeSH Conditions

Nephrosis Nephrotic Syndrome Syndrome Thromboembolism Venous Thromboembolism

Other Conditions

Stopping Reasons

The primary objectives were achieved.

Limitations And Caveats

N/A

Result Publications

Matyjek A, Rymarz A, Nowicka Z, Literacki S, Rozmyslowicz T, Niemczyk S. Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome-A Single Center Prospective Study. J Clin Med. 2021 Dec 6;10(23):5709. doi: 10.3390/jcm10235709. [PMID: 34884411] [DOI: 10.3390/jcm10235709]

Annotations

Category Annotations

No annotators decided on categories yet

Intervention Annotations

#	Outdated	Intervention				Condition
#	Outdated	Name		Route	DrugBank ID	Condition